Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

The emergence of advanced therapy medicinal products (ATMPs) including cell therapies, has led to many bioanalytical ...

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...